Session Information
2007 Midyear Clinical Meeting
The Pharmacist's Role in Hypertension Management Following ALLHAT
Track: Educational Session
Program Code: 222-L01
Date: Monday, December 3, 2007
Time: 4:00 p.m. - 5:00 p.m.
Location:
Veronese 2401/2402/2501/2502MEETING PLANNING ASSOCIATE:
Dr. Barry Carter, PharmD, FCCP, Professor, Colleges of Pharmacy and Medicine, The University of Iowa
PRESENTER:
Dr. Barry Carter, PharmD, FCCP, Professor, Colleges of Pharmacy and Medicine, The University of Iowa
LEARNING OBJECTIVES
- Suggest management strategies for a patient with hypertension based on The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) study and the seventh report from the Joint National Committee (JNC-7) guidelines.
- Develop an antihypertensive regimen for patients with poorly controlled blood pressure (BP) that includes a thiazide diuretic and discuss the difference between chlorthalidone and hydrochlorothiazide (HCTZ).
- Discuss when a two-drug antihypertension regimen is appropriate as initial therapy for a patient with hypertension.
- Explain the pros and cons for the use of a thiazide diuretic for most patients with hypertension.
- Outline features of a physician/pharmacist collaborative model for managing hypertension that achieves high BP control rates using principles from ALLHAT and JNC-7.
Audio Synchronized to PowerPoint with MP3 Download
(Code: 222-L01)
This session is a part of: